Danlos, F., Marabelle, A., Ferrara, R., Besse, B., Cassard, L., Chaput, N., . . . Caramella, C. CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers. BMJ Publishing Group.
Chicago Style (17th ed.) CitationDanlos, Francois-Xavier, et al. CD8+PD-1+ to CD4+PD-1+ Ratio (PERLS) Is Associated with Prognosis of Patients with Advanced NSCLC Treated with PD-(L)1 Blockers. BMJ Publishing Group.
MLA (9th ed.) CitationDanlos, Francois-Xavier, et al. CD8+PD-1+ to CD4+PD-1+ Ratio (PERLS) Is Associated with Prognosis of Patients with Advanced NSCLC Treated with PD-(L)1 Blockers. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.